Barclays Maintains Rapid7 Inc to Overweight with Price Target $17.00

Brokerage firm Barclays Maintains its rating on Rapid7 Inc(NASDAQ:RPD). In a research note issued to the investors, the brokerage major Raises the price-target to $17.00 per share. The shares have been rated Overweight. The rating by Barclays was issued on Aug 9, 2016.

Rapid7 Inc (RPD) shares turned negative on Wednesdays trading session with the shares closing down -0.11 points or -0.67% at a volume of 1,95,202. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $16.4. The peak price level was also seen at $16.4 while the days lowest was $16. Finally the shares closed at $16.27. The 52-week high of the shares is $25.38 while the 52-week low is $9.05. According to the latest information available, the market cap of the company is $685 M.

Rapid7 Inc(RPD) last announced its earnings results on Aug 8, 2016 for Fiscal Year 2016 and Q2.Company reported revenue of $37.27M. Analysts had an estimated revenue of $36.29M. Earnings per share were $-0.22. Analysts had estimated an EPS of $-0.24.

Rapid7 Inc. is a provider of security data and analytics solutions.The Company offers three solution groups: threat exposure management which includes its Nexpose Metasploit and AppSpider products; incident detection and response which include its UserInsight product and its incident response services and security advisory services. Its threat exposure management solutions reflect its evolution and enhancement of management tools to encompass a set of data including real-world threat information and analytics that facilitate systematic remediation. Its incident detection and response solutions offer customers a combination of product-based analytics as well as services to help detect attackers and respond to attacks once they are discovered. Its security advisory services help organizations implement and manage an analytics-driven security approach by looking at their security programs and providing them with advice related to prevention detection and correction.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *